SIA
CLBT icon

SkyView Investment Advisors’s Cellebrite CLBT Stock Holding History

SkyView Investment Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$551K Buy
40,005
+967
+2% +$14.6K 0.07% 181
2025
Q4 		$704K Buy
39,038
+127
+0.3% +$2.28K 0.09% 170
2025
Q3 		$721K Buy
38,911
+1,203
+3% +$18.9K 0.09% 166
2025
Q2 		$597K Buy
37,708
+970
+3% +$17.3K 0.09% 181
2025
Q1 		$714K Buy
36,738
+1,619
+5% +$34.1K 0.11% 160
2024
Q4 		$774K Buy
+35,119
New +$676K 0.12% 142

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SkyView Investment Advisors's CLBT Position: Q1 2026 in Review

SkyView Investment Advisors increased its Cellebrite (CLBT) stake by 2.5% in Q1 2026, buying an estimated $14.6K and bringing the position to 40,005 shares worth $551K. The position accounts for 0.07% of the portfolio, ranked #181.

SkyView Investment Advisors first reported a position in CLBT in Q4 2024 and has held it in 6 quarters since. The position peaked at $774K in Q4 2024. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • SkyView Investment Advisors held 40,005 shares of Cellebrite worth $551K as of Q1 2026.
  • SkyView Investment Advisors bought 967 Cellebrite shares in Q1 2026, an estimated $14.6K.
  • Cellebrite made up 0.07% of SkyView Investment Advisors's portfolio in Q1 2026, its #181 holding.
  • SkyView Investment Advisors first reported a position in Cellebrite in Q4 2024 and has held it in 6 quarters since.
  • SkyView Investment Advisors's Cellebrite position peaked at $774K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.